Investigators | Year | Patient no. | Preoperative treatment | Mean operative time/min | Mean blood loss/ml | Type of UD | Conversion rate/% | Complication | Mean postoperative hospitalization/day | Follow-up time/mon | Follow-up outcome | 5-year survival |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Pomel et al. [3] | 2003 | 1 | Chemoradiotherapy | 540 | 250 | Bricker | 0 | 0 | 16 | NS | NS | NS |
Lin et al. [23] | 2004 | 1 | Radiotherapy | 540 | 200 | US | 0 | UTI, SSI | 19 | 12 | Alive (disease free) | NS |
Uzan et al. [24] | 2005 | 2 | Chemoradiotherapy | 510 (480–540) | 525 (250–800) | Bricker | 0 | UTI, CRAF | 23.5 (17–30) | 8.5 (6–11) | Dead | NS |
Puntambekar et al. [25] | 2006 | 2 | NS | 240 | 200 | Wet colostomy | 0 | NS | 3.5 | 15 | NS | NS |
[5] | 2009 | 7 | NS | 230 (±15) | 250 (±50) | Five wet colostomy, two Bricker | 0 | NS | 8 (7–21) | 11 (4–24) | Four died of distant metastases, three disease free more than a year | NS |
Skrovina M et al. [26] | 2006 | 3 | 1 NS 2 nCRT | NS | NS | Bricker | NS | One Wound dehiscence and AMI | NS | NS | NS | NS |
Patel H et al. [27] | 2009 | 2 | Chemoradiotherapy | 330 | 1200 | Bricker | 0 | NS | 11 | NS | NS | NS |
Lim PC [28] (robotic-assisted) | 2009 | 1 | Chemoradiotherapy | 540 | 1000 | Bricker | 0 | NS | 23 | NS | NS | NS |
Figueiredo et al. [29] | 2010 | 1 | nCRT | 450 | NS | NS | NS | NS | NS | 10 | Alive (no evidence of recurrence and metastasis) | NS |
Vasilescu et al. [30] (entirely robotic) | 2011 | 1 | Radiotherapy | 250 | 365 | Cutaneous ureterostomy | 0 | 0 | 11 | NS | NS | NS |
Mukai et al. [31] | 2013 | 1 | nCRT | 831 | 600 | Cutaneous ureterostomy | 0 | Ileus | 29 | NS | NS | NS |
Total | Â | 22 | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |